via pharmatimes.com
The lawsuit alleges that Amylin "is a company at a crossroads and that stockholders should be entitled to nominate a new slate of directors committed to pursuing a sale of the company". Mr Icahn has also threatened the firm with another lawsuit if it does not produce copies of its books and records by Wednesday.
No comments:
Post a Comment